Mariner
CRBP icon

Mariner’s Corbus Pharmaceuticals CRBP Stock Holding History

Mariner’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Sell
11,636
-1,170
-9% -$11.1K ﹤0.01% 3315
2026
Q1 		$120K Sell
12,806
-4,280
-25% -$36K ﹤0.01% 3287
2025
Q4 		$139K Sell
17,086
-3,754
-18% -$46.3K ﹤0.01% 3263
2025
Q3 		$264K Buy
20,840
+5,289
+34% +$50.3K ﹤0.01% 2931
2025
Q2 		$107K Buy
15,551
+3,261
+27% +$23.7K ﹤0.01% 3235
2025
Q1 		$65.3K Buy
+12,290
New +$108K ﹤0.01% 3261

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Mariner's CRBP Position: Q2 2026 in Review

Mariner reduced its Corbus Pharmaceuticals (CRBP) stake by 9.1% in Q2 2026, selling an estimated $11.1K and leaving 11,636 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

Mariner first reported a position in CRBP in Q1 2025 and has held it in 6 quarters since. The position peaked at $264K in Q3 2025. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Mariner held 11,636 shares of Corbus Pharmaceuticals worth $109K as of Q2 2026.
  • Mariner sold 1,170 Corbus Pharmaceuticals shares in Q2 2026, an estimated $11.1K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3315 holding.
  • Mariner first reported a position in Corbus Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Mariner's Corbus Pharmaceuticals position peaked at $264K in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.